Evidence map›Paper›PMID 42378035›Full record

ArticleThe Journal of clinical investigation2026

Cilia-to-basement membrane signaling is a biomechanical driver in models of autosomal dominant polycystic kidney disease.

Manal Mazloum, Brice Lapin, Rushdi Alghamdi, Jessica Vandensteen, Martine Burtin, Pascal Houillier, Lydie Cheval, Gilles Crambert, Vicky Scata, Camille Cohen and 19 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Manal MazloumUniversité Paris Cité, INSERM U1151, CNRS UMR 8235, Institut Necker Enfants Malades, Département Croissance et Signalisation, Paris, France.
Brice LapinInstitut Curie, Université PSL, Sorbonne Université, CNRS UMR 168, Physics of Cells and Cancer, Paris, France.
Rushdi AlghamdiUniversité Paris Cité, INSERM U1151, CNRS UMR 8235, Institut Necker Enfants Malades, Département Croissance et Signalisation, Paris, France.
Jessica VandensteenUniversité Paris Cité, INSERM U1151, CNRS UMR 8235, Institut Necker Enfants Malades, Département Croissance et Signalisation, Paris, France.
Martine BurtinUniversité Paris Cité, INSERM U1151, CNRS UMR 8235, Institut Necker Enfants Malades, Département Croissance et Signalisation, Paris, France.
Pascal HouillierSorbonne Université et Université Paris Cité, Centre de Recherche des Cordeliers, INSERM, CNRS, Paris, France.
Lydie ChevalSorbonne Université et Université Paris Cité, Centre de Recherche des Cordeliers, INSERM, CNRS, Paris, France.
Gilles CrambertSorbonne Université et Université Paris Cité, Centre de Recherche des Cordeliers, INSERM, CNRS, Paris, France.
Vicky ScataUniversité Paris Cité, INSERM U1151, CNRS UMR 8235, Institut Necker Enfants Malades, Département Croissance et Signalisation, Paris, France.
Camille CohenUniversité Paris Cité, Centre de Recherche sur l'Inflammation, INSERM U1149, EMR 8252, Paris, France.
Christoph SchellInstitute of Surgical Pathology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Michael RehmanDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Amandine AkaUniversité Paris Cité, INSERM U1151, CNRS UMR 8235, Institut Necker Enfants Malades, Département Croissance et Signalisation, Paris, France.
Karim OurahmounInstitut du Cerveau et de la Moelle Épinière, INSERM U975, CNRS UMR 7225, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France.
Rui BeneditoMolecular Genetics of Angiogenesis Group, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
E Wolfgang KuehnRenal Division, Faculty of Medicine, Department of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Stéphanie DescroixInstitut Curie, Université PSL, Sorbonne Université, CNRS UMR 168, Physics of Cells and Cancer, Paris, France.
Tilman BuschRenal Division, Faculty of Medicine, Department of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Michael KöttgenRenal Division, Faculty of Medicine, Department of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Serge GarbayUniversité Paris Cité, INSERM U1151, CNRS UMR 8235, Institut Necker Enfants Malades, Département Croissance et Signalisation, Paris, France.
Marie-Christine VerpontSorbonne Université, CoRaKiD, INSERM UMRS 1155, Hôpital Tenon, Paris, France.
Ellie TangSorbonne Université, CoRaKiD, INSERM UMRS 1155, Hôpital Tenon, Paris, France.
Brigitte LelongtSorbonne Université, CoRaKiD, INSERM UMRS 1155, Hôpital Tenon, Paris, France.
Nicolas CagnardBioinformatic Platform, INSERM UMR 1163, Imagine Institute, Université Paris Cité, Paris, France.
Stefan SomloDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Sylvie CoscoyInstitut Curie, Université PSL, Sorbonne Université, CNRS UMR 168, Physics of Cells and Cancer, Paris, France.
Fabiola TerziUniversité Paris Cité, INSERM U1151, CNRS UMR 8235, Institut Necker Enfants Malades, Département Croissance et Signalisation, Paris, France.
Amandine ViauUniversité Paris Cité, Imagine Institute, Laboratory of Hereditary Kidney Diseases, INSERM UMR 1163, Paris, France.
Frank BienaiméUniversité Paris Cité, INSERM U1151, CNRS UMR 8235, Institut Necker Enfants Malades, Département Croissance et Signalisation, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autosomal dominant polycystic kidney disease (ADPKD), the leading genetic cause of kidney failure, results from loss-of-function mutations in PKD1, encoding polycystin-1 (PC1). PC1 localizes to the primary cilium. In the absence of PC1, adverse signaling from the primary cilium orchestrates cyst formation, but the biomechanical underpinnings of this cilia-dependent cyst activation (CDCA) remain unclear. Combining tubule-specific orthologous mouse models with a tubule-on-chip platform, we show that PC1 and cilia govern the composition, mechanical properties, and shape of the tubular basement membrane (TBM), the principal rigid determinant of tubule geometry. PC1 loss triggered TBM thinning, heparan sulfate enrichment, and deformation, leading to distension, preferentially of the distal nephron. These changes were driven by a cilia-dependent transcriptional program, with GLIS2 - a key CDCA effector - participating as a downstream mediator. Reduction of TBM stiffness amplified Pkd1-/- tubule-on-chip dilation and increased cyst formation in vivo. Conversely, increasing luminal pressure through ureteral obstruction induced disproportionate distension of Pkd1-deficient tubules and triggered an irreversible cystogenic program. Together, these findings establish a TBM-centered biomechanical model of ADPKD in which tubule deformation is governed by both basolateral and luminal mechanical factors and identify the cilium/TBM axis, operating in part through GLIS2, as a central driver of cystogenesis.

Indexed as

Basement MembraneCiliaPolycystic Kidney, Autosomal DominantSignal TransductionAnimalsBiomechanical PhenomenaDisease Models, AnimalHumansKidney TubulesMiceMice, KnockoutTRPP Cation ChannelsTRPP Cation ChannelsChronic kidney diseaseGeneticsMouse modelsNephrologyProteoglycans

Identifiers

PMID42378035
PMCPMC13574157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.